On February 3, 2016, Scott Youmans announced that he is departing as the Chief Operating Officer of Atossa Genetics Inc. with an expected effective date of February 12, 2016. Mr. Youmans is pursuing other professional activities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 USD | +5.50% | -4.17% | +30.68% |
Jul. 02 | Atossa Therapeutics Names Heather Rees CFO | MT |
Jul. 02 | Atossa Therapeutics, Inc. Appoints Heather Rees as Chief Financial Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.68% | 145M | |
+17.09% | 44.63B | |
+42.10% | 40.46B | |
-9.70% | 38.07B | |
+33.28% | 32.27B | |
-8.98% | 27.3B | |
+13.37% | 26.53B | |
+44.11% | 14.06B | |
+32.33% | 12.54B | |
-7.26% | 11.28B |
- Stock Market
- Equities
- ATOS Stock
- News Atossa Therapeutics, Inc.
- Atossa Genetics Announces Resignation of Scott Youmans as a Chief Operating Officer, Effective February 12, 2016